117 related articles for article (PubMed ID: 23479161)
1. Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome.
Lecke SB; Morsch DM; Spritzer PM
Genet Mol Res; 2013 Feb; 12(4):4292-6. PubMed ID: 23479161
[TBL] [Abstract][Full Text] [Related]
2. Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome.
Lecke SB; Mattei F; Morsch DM; Spritzer PM
Fertil Steril; 2011 May; 95(6):2044-9. PubMed ID: 21419406
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
[TBL] [Abstract][Full Text] [Related]
4. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
[TBL] [Abstract][Full Text] [Related]
5. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome.
Echiburú B; Pérez-Bravo F; Galgani JE; Sandoval D; Saldías C; Crisosto N; Maliqueo M; Sir-Petermann T
Steroids; 2018 Feb; 130():15-21. PubMed ID: 29273198
[TBL] [Abstract][Full Text] [Related]
6. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome.
Kale-Gurbuz T; Akhan SE; Bastu E; Telci A; Iyibozkurt AC; Topuz S
J Pediatr Adolesc Gynecol; 2013 Feb; 26(1):27-30. PubMed ID: 23158749
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
Chen CI; Hsu MI; Lin SH; Chang YC; Hsu CS; Tzeng CR
Gynecol Endocrinol; 2015 Apr; 31(4):264-8. PubMed ID: 25423261
[TBL] [Abstract][Full Text] [Related]
9. Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients.
Luque-Ramírez M; Alvarez-Blasco F; Escobar-Morreale HF
Obesity (Silver Spring); 2009 Jan; 17(1):3-9. PubMed ID: 18997670
[TBL] [Abstract][Full Text] [Related]
10. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.
Tao T; Li S; Zhao A; Zhang Y; Liu W
Eur J Endocrinol; 2012 Nov; 167(5):705-13. PubMed ID: 22945299
[TBL] [Abstract][Full Text] [Related]
11. Evidence for altered adipocyte function in polycystic ovary syndrome.
Carmina E; Orio F; Palomba S; Cascella T; Longo RA; Colao AM; Lombardi G; Lobo RA
Eur J Endocrinol; 2005 Mar; 152(3):389-94. PubMed ID: 15757855
[TBL] [Abstract][Full Text] [Related]
12. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
13. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A
Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308
[TBL] [Abstract][Full Text] [Related]
14. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676
[TBL] [Abstract][Full Text] [Related]
15. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression.
Dolezalova R; Lacinova Z; Dolinkova M; Kleiblova P; Haluzikova D; Housa D; Papezova H; Haluzik M
Clin Endocrinol (Oxf); 2007 Nov; 67(5):674-8. PubMed ID: 17953628
[TBL] [Abstract][Full Text] [Related]
16. Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study.
Krentz AJ; von Mühlen D; Barrett-Connor E
Metabolism; 2012 Sep; 61(9):1238-41. PubMed ID: 22560129
[TBL] [Abstract][Full Text] [Related]
17. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
20. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
Kort DH; Kostolias A; Sullivan C; Lobo RA
Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
